USPTO trademark

HYPERCEPT

AllowedUSPTOWord markClass 9Class 41Class 42Class 44

"HYPERCEPT" is a word mark owned by Astellas Gene Therapies, Inc., filed at the USPTO on December 4, 2025. It has been allowed and covers classes 9, 41, 42 and 44.

Get this data via the API
Official USPTO record
HYPERCEPT trademark as filed
As filed with the USPTO
Status
Allowed
Since July 7, 2026
Filed
December 4, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99529787
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns HYPERCEPT

The owner and representative on file with the office.

Owner

Astellas Gene Therapies, Inc.

South San Francisco, United States

Representative

Christopher Bolinger

Goods and services

What the mark covers

The products and services HYPERCEPT is filed for, grouped by Nice class.

  • Downloadable software for use by eye care professionals in analyzing optical coherence tomography (OCT) images; downloadable software featuring artificial intelligence tools for detecting and tracking progression of geographic atrophy and other retinal conditions; downloadable electronic publications in the nature of periodicals and educational course materials in the field of ophthalmology, retinal imaging, and disease management

  • Educational services, namely, providing online non-downloadable publications in the nature of instructional materials, training courses, and resource guides for eye care professionals in the fields of geographic atrophy detection, OCT imaging interpretation, and patient management; providing a website featuring non-downloadable videos and informational articles in the field of ophthalmology

  • Software-as-a-service (SaaS) and platform-as-a-service (PaaS) featuring computer software utilizing artificial intelligence for the analysis of retinal images and medical imaging data; providing online non-downloadable software for uploading, processing, and analyzing OCT scans; electronic data storage services for ophthalmic imaging; cloud-based data aggregation and analytics services supporting clinical research in the field of ophthalmology; data anonymization and tokenization services for medical imaging; software-as-a-service (SaaS) featuring software for use by eye care professionals in analyzing optical coherence tomography (OCT) images; SaaS featuring artificial intelligence software for detecting and tracking progression of geographic atrophy and other retinal conditions

  • Providing medical information and medical imaging interpretation support services to eye care professionals; consulting services in the field of ophthalmology regarding detection and progression of geographic atrophy; providing clinical data analytical services supporting disease diagnosis and management

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Examiner's amendment entered
  7. Notification of examiners amendment e-mailed
  8. Examiners amendment e-mailed
  9. Examiners amendment -written
  10. Assigned to examiner

3 earlier steps on the official record.

FAQ

About HYPERCEPT

Who owns the trademark "HYPERCEPT"?

The USPTO trademark "HYPERCEPT" (application 99529787) is owned by Astellas Gene Therapies, Inc.

What is the status of "HYPERCEPT"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull HYPERCEPT and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b6c-d116-73df-92a6-97de3d9c5b7d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b6c-d116-73df-92a6-97de3d9c5b7d",
  "object": "trademark",
  "mark_text": "HYPERCEPT",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99529787",
  "filing_date": "2025-12-04",
  "nice_classes": [
    9,
    41,
    42,
    44
  ],
  "owners": [
    {
      "name": "Astellas Gene Therapies, Inc.",
      "entity_id": null
    }
  ]
}